Media Thread, page-12161

Mate, sorry to say but Hervaxx is finished and in the process of getting burried.

Im surprised the imugene army hasn't picked it up. I guess there really is some bad bias on these threads. No one likes posting bad news.

The Next Herzion trail was updated on the 29/02/2024.
Their change was to the total recruitment numbers. Was 30 has now been changed to 7. No change to the trial primary completion date being this month 31/03/2024.

The trial has been running for 18 months targeting 30 enrollments. They could only get 7, so they are wrapping the trial up here and putting Hervaxx back on the self.

Im very disappointed by it. From dance cards are full, goose in the window, commercial supply agreements. To complete radio silence for 18 months. And only able to recruit 7 of of 30 patients for drug has already completed a phase 2 study with statically significant benefit to those participants.

Just goes to show how hard it is to pick a winner in bio tech.
fourdollars called it correctly.

Im still optimistic Azercel and CF33 and deliver where Hervaxx has been a bust.

DYOR not advice